For the Quarter Ending September 2025
North America
• In the United States and Canada, the Dipotassium EDTA Price Index declined by ~5.1% quarter-over-quarter, driven by easing precursor costs and subdued discretionary purchasing.
• The average Dipotassium EDTA price for the quarter was approximately USD 2,790/MT for CFR East Coast North America imports (conservative estimate based on regional spreads).
• Dipotassium EDTA Spot Price stayed muted as formaldehyde and EDA softening lowered production cost support and distributors maintained existing stocks.
• Dipotassium EDTA Price Forecast points to limited near-term volatility, with marginal downside if precursor softness continues.
• Dipotassium EDTA Production Cost Trend eased as feedstock prices fell, offsetting other cost pressures and limiting upward pass-through.
• Dipotassium EDTA Demand Outlook remains steady, with pharmaceutical and personal care procurement largely need-based and programmatic.
• Moderate importer and distributor inventories, together with steady import arrivals, kept the market well supplied and limited spot spikes.
• Logistics and inland transport functioned normally, enabling regular dispatches and supporting orderly market trading.
Why did the price of Dipotassium EDTA change in September 2025 in North America?
• Declines in formaldehyde and EDA feedstock costs reduced production expenses, easing price levels.
• Balanced inventories and cautious replenishment by formulators limited urgent buying, keeping spot activity subdued.
• Stable logistics and regular import arrivals prevented supply tightness, so movements were driven primarily by cost and demand balance.
APAC
• In India, the Dipotassium EDTA Price Index fell by 5.37% quarter-over-quarter, driven by feedstock costs.
• The average Dipotassium EDTA price for the quarter was approximately USD 2778.78/MT remained broadly stable.
• Dipotassium EDTA Spot Price muted as formaldehyde and EDA softening lowered the Production Cost Trend.
• Dipotassium EDTA Price Forecast indicates marginal variations driven by steady demand and supply limiting volatility.
• Dipotassium EDTA Demand Outlook remains stable with pharmaceutical and personal care procurement following need-based purchasing.
• The Dipotassium EDTA Price Index stability reflected moderate inventories, limited export support, and uninterrupted logistics.
• Domestic producers operated at stable capacity, enabling dispatches while suppliers maintained disciplined offers and allocations.
• Monsoon season slightly affected transport; Dipotassium EDTA Spot Price and supply remained largely resilient nationwide.
Why did the price of Dipotassium EDTA change in September 2025 in APAC?
• Softened formaldehyde and EDA feedstock costs reduced production expenses, exerting downward pressure on price levels.
• Stable production and uninterrupted inland logistics maintained supply availability, preventing any sharp upward price movements.
• Moderate downstream inventories and need-based pharmaceutical procurement constrained immediate demand-driven price support this month materially.
Europe
• In Germany and EU import hubs, the Dipotassium EDTA Price Index fell by ~4.9% quarter-over-quarter, reflecting softer feedstock-linked costs and muted procurement.
• The average Dipotassium EDTA price for the quarter was approximately USD 2,820/MT for CFR Rotterdam imports (conservative regional estimate).
• Dipotassium EDTA Spot Price remained muted as weaker formaldehyde and EDA markets lowered production cost support for sellers.
• Dipotassium EDTA Price Forecast indicates marginal downside risk near term, with range-bound trading as demand and supply remain balanced.
• Dipotassium EDTA Production Cost Trend eased following lower precursor prices, keeping cost pass-through limited.
• Dipotassium EDTA Demand Outlook stays steady but unspectacular, with personal care and pharmaceutical buyers following need-based purchasing rather than speculative restocking.
• Moderate European inventories and predictable port operations (Rotterdam/Hamburg) constrained price swings and supported orderly tendering.
• Domestic distributors applied disciplined replenishment, allowing suppliers to maintain stable offers and allocations.
Why did the price of Dipotassium EDTA change in September 2025 in Europe?
• Softer formaldehyde and EDA feedstock prices reduced production cost pressure, allowing sellers to hold offers lower.
• Balanced inventories and cautious, need-based purchasing by formulators limited immediate buying urgency.
• Efficient port logistics and steady import arrivals prevented supply disruptions, keeping price movements modest.
For the Quarter Ending June 2025
North America
• The Dipotassium EDTA Spot Price in North America saw stable-to-soft movement in Q2 2025, mirroring import-linked sentiment from Asia and restrained offtake across pharmaceutical and food sectors.
• The Price Index remained largely neutral, with an estimated fluctuation of -1% to +0.5% through the quarter, as import prices softened and domestic demand stayed subdued.
• The Dipotassium EDTA Production Cost Trend was influenced by declining global input prices, particularly for formaldehyde and EDTA precursors, leading to reduced import cost pressures for U.S. formulators.
• The Dipotassium EDTA Demand Outlook showed weakness in Q2, as several pharmaceutical companies maintained high opening inventories, avoiding restocking, while the food preservation segment remained inactive.
• Buyers in personal care and hygiene product sectors continued routine procurement, but volumes were insufficient to shift overall market pricing or consumption significantly.
• Distribution channels across the U.S. functioned efficiently, and no freight challenges were recorded during the quarter, enabling stable availability and conservative procurement practices.
• The Dipotassium EDTA Price Forecast for North America points toward cautious sentiment, with any potential price rebounds in Q3 hinging on export-import parity adjustments and seasonal cleaning agent demand.
• Local formulators in contract manufacturing opted to delay bulk purchases, citing soft price trends and uncertain Q3 demand scenarios in OTC preparations and topical formulations.
• In July 2025, prices decreased slightly by an estimated 0.3–0.5% due to continued weak buying interest and pass-through effect of lower Asian export offers.
Asia Pacific (APAC)
• The Dipotassium EDTA Spot Price in Indian market remained stable in Q2 and closed at USD 2872/MT in June. It followed a marginal increase of 0.45% that was backed by softened input costs and steady downstream demand.
• The Price Index showed a net Q2 growth of approx. 0.8%, with only modest price variation across April (+1.17%), May (-5.77%) and June (+0.45%) due to alternating cost and demand influences.
• The Dipotassium EDTA Production Cost Trend saw relief from falling feedstock costs—particularly formaldehyde and EDA—helping suppliers maintain margin stability and avoid sharp price hikes.
• The Dipotassium EDTA Demand Outlook in APAC remained consistent in Q2 with balanced consumption from pharmaceutical formulations, nutraceuticals and personal care sectors throughout the summer.
• Buyers across India adopted need-based procurement, aided by well-maintained inventories and absence of supply-side bottlenecks, which stabilized price sentiment despite seasonal activity.
• In April, export and domestic demand improved moderately, lifting prices slightly, but was followed by a May dip due to weak pharmaceutical uptake. A modest June rebound kept quarterly movement subdued.
• The Dipotassium EDTA Price Forecast for APAC suggests a continued stable-to-soft trend into early Q3 as input prices stabilize and consumer industries maintain cautious procurement cycles.
• There were no logistics disruptions during India’s monsoon, enabling smooth distribution, which further muted any aggressive price fluctuations in the region.
• In July 2025, prices are expected to remain stable or soften slightly due to accumulated inventories and restrained buying in the pharmaceutical segment, despite ongoing cosmetic sector support.
Europe
• The Dipotassium EDTA Spot Price in Europe remained stable with slight weakness through Q2 2025, following similar dynamics as APAC and North America. Prices ranged within a narrow band of USD 2900–2950/MT.
• The Price Index showed a quarter-on-quarter drop of approximately 1.5%, led by weak demand from pharmaceuticals and a shift toward lower-cost chelating alternatives in formulation planning.
• The Dipotassium EDTA Production Cost Trend benefited from cheaper Asian imports and declining raw material prices, giving European blenders price negotiation leverage in bulk purchasing rounds.
• The Dipotassium EDTA Demand Outlook was affected by inventory saturation in Q1, limiting Q2 uptake, though cosmetics and cleaning agents sectors continued with standard consumption cycles.
• Formulators in Germany, France, and Italy avoided long-term procurement, citing uncertainty around Q3 consumption and broader EU pharmaceutical output volatility.
• The market witnessed active price negotiations in May–June, but no significant supply shortage or production constraints occurred to disrupt availability.
• With freight rates from Asia softening, importers leveraged lower-cost landed cargoes to support domestic formulation operations, restraining any price rally.
• The Dipotassium EDTA Price Forecast for Europe remains neutral for early Q3, pending stronger demand indicators or supply chain tightening, which is currently absent.
• In July 2025, Dipotassium EDTA prices in Europe declined modestly, driven by reduced pharmaceutical demand, availability of low-cost imports, and subdued regional production activity.
For the Quarter Ending March 2025
North America
In North America, Dipotassium EDTA prices showed a stable to slightly firm trend through the first quarter of 2025. While exact price change data was not widely reported, market behaviour suggests a slight upward push in line with trends observed in global markets.
Procurement activity in pharmaceuticals and food sectors was paced and steady. Buyers avoided excessive stocking but maintained healthy inventory levels. There was no major disruption in supply. Most shipments reached on time, and there were no sharp changes in freight charges. The transition from winter to spring did not bring much fluctuation in consumption patterns. However, suppliers saw steady inquiries from food and beverage manufacturers. This helped keep the sentiment slightly positive.
Some mild effects of trade regulations and tariff adjustments were also noted. These were not disruptive but did influence the pricing environment slightly. Sellers did not push prices aggressively, and buyers were ready to accept marginal increases for confirmed deliveries. Overall, the market moved in a balanced manner. Price firmness appeared more due to disciplined procurement and moderate but consistent demand.
Asia Pacific
In the Asia Pacific region, Dipotassium EDTA prices increased by around 2.73 percent during the first quarter of 2025. The rise came as suppliers handled demand steadily across pharmaceutical, food and personal care sectors. There was no sharp jump in consumption, but procurement remained regular. Buyers preferred timely restocking to avoid future delays. This kept inventories at a safe level. Supply chains operated well in entire region despite some minor delays around the Lunar New Year.
The seasonal transition in APAC region and holidays in China led to shorter working periods which mildly affected trading pace. However, overall availability was not disrupted. Demand across the region stayed firm especially in nutraceutical and skin care applications. Some buyers increased booking volumes in the later part of the quarter. This added to the upward price push. The market tone stayed positive but stable. There was no sign of panic buying or overstocking. Logistics remained smooth, and prices moved upward mainly due to consistent demand and stable procurement.
Europe
In Europe, the Dipotassium EDTA market remained relatively stable through the first quarter of 2025. There were no significant shifts in pricing, but a soft upward movement was noted in key markets. This reflected the broader global trend of consistent demand and European market mirrored the same.
Buyers in Europe followed cautious procurement strategies. Orders were placed in smaller batches based on usage and forecasted needs. Inventory remained well managed. Suppliers did not report any major production changes. Supply was available across key regions without notable delay. Demand from pharmaceutical and personal care sectors supported a mild uptick in sentiment. Skin care and hair care applications saw steady consumption. Buyers preferred confirmed deliveries from trusted sources and avoided speculative buying.
There was no panic or sudden rise in consumption. Freight and logistics across the region worked without major interruption. Even though local pricing data was not widely disclosed, market behaviour indicated a soft and manageable price environment. Slight firmness in pricing seemed driven more by demand stability and regular restocking than by any tightness in availability.
For the Quarter Ending December 2024
North America
The North American Dipotassium EDTA market navigated a complex economic landscape in Q4 2024, characterized by nuanced supply chain dynamics and resilient industrial demand. Market performance reflected moderate supply constraints stemming from limited domestic production capacity and intermittent import challenges.
Manufacturing sector performance demonstrated remarkable adaptability, signaling sustained growth potential. Strategic priorities centered on supply chain optimization, technological process automation, and sophisticated cost management approaches. Critical downstream sectors, including food processing, pharmaceutical manufacturing, and personal care industries, maintained robust consumption patterns, providing essential market stability.
The market's inherent resilience emerged through strategic inventory adjustments and adaptive pricing mechanisms. While experiencing temporary supply-demand imbalances, the North American Dipotassium EDTA ecosystem showcased its capacity to recalibrate and respond to evolving economic conditions. Technological innovation and consistent industrial demand positioned the market for potential future growth, underlining the sector's structural strength and strategic importance in advanced manufacturing value chains.
Asia
The Indian Dipotassium EDTA market demonstrated Stable bearish momentum in Q4 2024, driven by significant demand-supply imbalances and rising domestic consumption. Supply constraints stemmed from reduced imports, limited production capacity, and labor shortages during the festive season. Meanwhile, downstream sectors saw heightened demand due to pre-winter procurement activities and strong industrial consumption. Elevated spot market premiums reflected structural market strength, with price gains driven by demand fundamentals rather than speculative activity.
India’s manufacturing sector also showed resilience, with the PMI peaking at 57.5 in October before moderating to 56.5 in November, signaling sustained growth despite rising input costs and competitive pressures. The sector focused on automation, supply chain optimization, and product innovation to mitigate cost inflation, maintain productivity, and ensure long-term growth.
As the quarter progressed, deliberate inventory adjustments and currency depreciation created a temporary pricing standoff in the Dipotassium EDTA market. However, with stable downstream demand in food, cosmetics, and pharmaceuticals, the market is poised to stabilize, showcasing its resilience amid evolving dynamics. As Q4 2024 concluded, the latest quarter-ending price for Dipotassium EDTA 98% Ex-Vadodara in India settled at USD 2867.09/MT showcasing average quarterly decline of 0.67%, further underscoring the prevailing negative pricing environment in the region.
Europe
The European Dipotassium EDTA market in Q4 2024 witnessed fluctuating prices, shaped by its dependence on imports from India and ripple effects from declining APAC prices. Despite delayed impacts due to contractual commitments and logistical timelines, the region faced challenges in maintaining a balance between competitive import pricing and sufficient inventory levels.
Cautious procurement strategies emerged across downstream industries, amplifying market uncertainty and contributing to a restrained buying sentiment. European market prices trended downward gradually, mirroring but not fully matching the sharper declines in India. Pricing dynamics were closely tied to Indian export rates, with freight costs and Euro-USD currency fluctuations adding complexity to the landscape. This intricate interplay of global influences highlighted the region’s vulnerability to external market pressures.
As the quarter closed, the European market showcased resilience while adapting to evolving conditions. With these trends expected to persist, stakeholders remain focused on navigating challenges and seizing opportunities in the upcoming quarters.
